Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy

Fig. 2

(a) Area under the curve (AUC) cumulative exposure of 24-h serum cortisone (b) AUC day-time cumulative exposure of cortisone (c) AUC night-time cumulative exposure of cortisone in patient groups and controls. ns, not significant, p value> 0.05, *p value < 0.05, **p value < 0.01, ***p value< 0.001

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us